Tyra Biosciences, Inc. announced that it has raised $106 million in a round of funding led by new investor Nextech Invest Ltd. on March 31, 2021. The transaction included participation from new investors Cormorant Asset Management, LLC, Janus Henderson Group plc, Logos Global Management, L.P., BVF Partners, L.P. and existing investors Alta Partners LP, RA Capital Management, LLC, Boxer Capital LLC and Canaan Partners. As part of the transaction, Melissa McCracken from Nextech Invest Ltd. will join the company's board of directors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.96 USD | +2.29% | +20.87% | +36.75% |
Mar. 20 | HC Wainwright Adjusts Tyra Biosciences Price Target to $23 From $19, Maintains Buy Rating | MT |
Mar. 19 | Tyra Biosciences Q4 Net Loss Widens | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.75% | 973M | |
+24.80% | 48.09B | |
+47.36% | 40.62B | |
-2.83% | 40.43B | |
-6.20% | 28.36B | |
+7.67% | 24.89B | |
-19.04% | 19.01B | |
+29.46% | 12.09B | |
-0.91% | 11.88B | |
-0.59% | 11.8B |
- Stock Market
- Equities
- TYRA Stock
- News Tyra Biosciences, Inc.
- Tyra Biosciences, Inc. announced that it has received $106 million in funding from a group of investors